Polyrizon ltd. announces closing of $17.0 million private placement

Raanana, israel, april 01, 2025 (globe newswire) -- polyrizon ltd. (nasdaq: plrz) (the “company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement of approximately $17.0 million of ordinary shares and/or pre-funded and investor warrants at a price of $0.48 per ordinary unit.

PLRZ Ratings Summary

PLRZ Quant Ranking